319 related articles for article (PubMed ID: 8095738)
1. Therapy of left ventricular dysfunction: implications of recent therapeutic trials and future directions for therapy.
Pitt B
Schweiz Med Wochenschr; 1993 Feb; 123(8):342-8. PubMed ID: 8095738
[TBL] [Abstract][Full Text] [Related]
2. Congestive heart failure: new therapeutic strategies.
Pitt B
Clin Cardiol; 1992 Sep; 15 Suppl 1():I2-4. PubMed ID: 1395211
[TBL] [Abstract][Full Text] [Related]
3. Blockade of the renin-angiotensin system. Effect on mortality in patients with left ventricular systolic dysfunction.
Pitt B
Cardiol Clin; 1994 Feb; 12(1):101-14. PubMed ID: 8181019
[TBL] [Abstract][Full Text] [Related]
4. [Digoxin and angiotensin-converting enzyme inhibitors in the treatment of chronic congestive heart failure].
Thery C
Therapie; 1994; 49(3):211-8. PubMed ID: 7878586
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin-converting enzyme inhibitors post-myocardial infarction.
Young JB
Cardiol Clin; 1995 Aug; 13(3):379-90. PubMed ID: 7585774
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
[TBL] [Abstract][Full Text] [Related]
7. Tissue angiotensin-converting enzyme inhibitors for the prevention of cardiovascular disease in patients with diabetes mellitus without left ventricular systolic dysfunction or clinical evidence of heart failure: a pooled meta-analysis of randomized placebo-controlled clinical trials.
Saha SA; Molnar J; Arora RR
Diabetes Obes Metab; 2008 Jan; 10(1):41-52. PubMed ID: 18095949
[TBL] [Abstract][Full Text] [Related]
8. [New aspects of ACE inhibitor treatment of heart failure].
Dietz R; Osterziel KJ
Z Kardiol; 1996; 85 Suppl 6():241-6. PubMed ID: 9064971
[TBL] [Abstract][Full Text] [Related]
9. [The role of ACE inhibitors in heart failure. Lessons of CONSENSUS, SOLVD and V-HeFTII].
Dessì-Fulgheri P; Paci MV; Rappelli A
Ann Ital Med Int; 1994 Oct; 9 Suppl():16S-18S. PubMed ID: 7857751
[TBL] [Abstract][Full Text] [Related]
10. [New knowledge on the subject of therapy in cardiac decompensation in the light of large trials].
Camerini F; Perkan A; Sinagra G; Di Lenarda A; Pinamonti B; Zecchin M
Ann Ital Med Int; 1994 Oct; 9 Suppl():68S-77S. PubMed ID: 7857761
[TBL] [Abstract][Full Text] [Related]
11. Medical therapy and prognosis in chronic heart failure. Lessons from clinical trials.
Ramahi TM; Lee FA
Cardiol Clin; 1995 Feb; 13(1):5-26. PubMed ID: 7796432
[TBL] [Abstract][Full Text] [Related]
12. [Heart insufficiency and life expectancy--the role of ACE inhibitors].
Kleber FX
Wien Med Wochenschr; 1990 Jan; 140(1-2):50-5. PubMed ID: 2408250
[TBL] [Abstract][Full Text] [Related]
13. The relevance of subgroup-specific treatment effects: the Studies Of Left Ventricular Dysfunction (SOLVD) revisited.
Parker AB; Yusuf S; Naylor CD
Am Heart J; 2002 Dec; 144(6):941-7. PubMed ID: 12486418
[TBL] [Abstract][Full Text] [Related]
14. [Rationale, characteristics and study design of PREAMI (Perindopril and Remodelling in the Elderly with Acute Myocardial Infraction)].
Magrini G; Nicolosi GL; Chiariello M; Ferrari R; Remme P; Tavazzi L
Ital Heart J; 2005 Nov; 6 Suppl 7():14S-23S. PubMed ID: 16485513
[TBL] [Abstract][Full Text] [Related]
15. Update on digoxin therapy in congestive heart failure.
Haji SA; Movahed A
Am Fam Physician; 2000 Jul; 62(2):409-16. PubMed ID: 10929703
[TBL] [Abstract][Full Text] [Related]
16. [Vasodilator agents in chronic heart failure: which is the best option?].
Corbalán R; Kunstmann S; Jalil J
Rev Med Chil; 1993 Jan; 121(1):81-8. PubMed ID: 8235172
[TBL] [Abstract][Full Text] [Related]
17. Effect of angiotensin-converting enzyme inhibitors in left ventricular dysfunction: results of the studies of left ventricular dysfunction in the context of other similar trials.
Yusuf S; Garg R; McConachie D
J Cardiovasc Pharmacol; 1993; 22 Suppl 9():S28-35. PubMed ID: 7514238
[TBL] [Abstract][Full Text] [Related]
18. [Indications for ACE inhibitors in the postinfarct period].
Ertl G; Gaudron P; Neubauer S; Hu K; Zdrojewski T; Horn M; Kochsiek K
Z Kardiol; 1994; 83 Suppl 4():65-74. PubMed ID: 7856283
[TBL] [Abstract][Full Text] [Related]
19. [Angiotensin converting enzyme inhibitors during acute phase of myocardial infarct].
Mazzotta G; Vecchio C
G Ital Cardiol; 1994 Jan; 24(1):59-70. PubMed ID: 8200499
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin-converting enzyme inhibitors in patients with coronary artery disease and absence of heart failure or left ventricular systolic dysfunction: an overview of long-term randomized controlled trials.
Danchin N; Cucherat M; Thuillez C; Durand E; Kadri Z; Steg PG
Arch Intern Med; 2006 Apr; 166(7):787-96. PubMed ID: 16606817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
